Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hypertrophy, Right Ventricular D017380 4 associated lipids
Strongylida Infections D017206 5 associated lipids
Tachycardia, Ventricular D017180 9 associated lipids
Liver Failure D017093 5 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Corneal Neovascularization D016510 8 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Helicobacter Infections D016481 21 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Blood Loss, Surgical D016063 6 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
HIV Infections D015658 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Leukemia, Eosinophilic, Acute D015472 3 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Ozaki Y et al. Potentiation of neutrophil biosynthesis of platelet-activating factor by cytochalasin B: evaluation of acetyltransferase activity. 1987 Nippon Ketsueki Gakkai Zasshi pmid:3687329
Ramesha CS et al. Identification and quantitation of PAF from psoriatic scales. 1987 Agents Actions pmid:3687590
Ponpipom MM et al. Structure-activity relationships of kadsurenone analogues. 1987 J. Med. Chem. pmid:3027330
Friedlander G et al. Renal effects of platelet-activating factor in the rat. 1987 Agents Actions pmid:3687594
McFall TL et al. Effect of group B streptococcal type-specific antigen on polymorphonuclear leukocyte function and polymorphonuclear leukocyte-endothelial cell interaction. 1987 Pediatr. Res. pmid:3037472
Hecker G et al. Potent inhibition of PAF-stimulated human platelets and polymorphonuclear leukocytes by the PGE1 analog OP-1206. 1987 Prog. Clin. Biol. Res. pmid:2444988
Desquand S et al. Interference of the PAF-acether antagonist BN 52021 with anaphylaxis in the guinea pig. 1987 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:2445183
Kurosawa M Effect of platelet activating factor on histamine release from rat mast cells. 1987 Agents Actions Suppl. pmid:2445185
Gerard NP Characterization of substance P contractile activity on isolated guinea pig lung tissues. 1987 J. Pharmacol. Exp. Ther. pmid:2447271
Alam I and Silver MJ Metabolism of 1-alkyl-2-acyl-GPC in human platelets in response to stimulation by thrombin. 1987 Thromb. Res. pmid:3576519
Kusner EJ et al. Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. 1987 Agents Actions pmid:3577957
Beijer L et al. The involvement of platelet activating factor in endotoxin-induced pulmonary platelet recruitment in the guinea-pig. 1987 Br. J. Pharmacol. pmid:2447993
Chesney CM et al. Triazolobenzodiazepines competitively inhibit the binding of platelet activating factor (PAF) to human platelets. 1987 Biochem. Biophys. Res. Commun. pmid:3579913
Belch JJ et al. Whole blood white cell aggregation: a novel technique. 1987 Thromb. Res. pmid:2448894
Casals-Stenzel J Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. 1987 Eur. J. Pharmacol. pmid:3582490
Fouque F and Vargaftig BB Potentiation and inhibition by clonidine of PAF-acether-induced human platelet activation. 1987 Eur. J. Pharmacol. pmid:3582495
Lellouch-Tubiana A et al. Interactions between granulocytes and platelets with the guinea-pig lung in passive anaphylactic shock. Correlations with PAF-acether-induced lesion. 1987 Int. Arch. Allergy Appl. Immunol. pmid:3583412
Patterson R et al. Evaluation of the effect of a platelet activating factor antagonist on platelet activating factor and Ascaris antigen-induced airway responses in rhesus monkeys. 1987 J. Lab. Clin. Med. pmid:3668360
Stewart AG and Piper PJ Actions of platelet-activating factor in the coronary circulation of the guinea pig in vitro. 1987 Prog. Clin. Biol. Res. pmid:3671383
Criscuoli M and Subissi A Paf-acether-induced death in mice: involvement of arachidonate metabolites and beta-adrenoceptors. 1987 Br. J. Pharmacol. pmid:2880624
Adamson LM et al. Mechanistic studies of early pregnancy associated thrombocytopenia (EPAT) in the mouse. 1987 Am J Reprod Immunol Microbiol pmid:3605486
Sugiura T et al. Transacylation of lyso platelet-activating factor and other lysophospholipids by macrophage microsomes. Distinct donor and acceptor selectivities. 1987 J. Biol. Chem. pmid:3805017
Edwards MC et al. Secretion and properties of a polypeptide factor generated by phorbol ester stimulation of human blood platelets. 1987 Biochem. Pharmacol. pmid:3606649
Sturk A et al. Platelet-activating factor: mediator of the third pathway of platelet aggregation? A study in three patients with deficient platelet-activating factor synthesis. 1987 J. Clin. Invest. pmid:3805272
Sturk A et al. Age-related deficiency of the synthesis of platelet activating factor by leukocytes from Zellweger patients. 1987 Blood pmid:3607283
Argyroudi-Akoyunoglou JH and Vakirtzi-Lemonias C Low-temperature fluorescence emission changes in thylakoids induced by acetyl glyceryl ether phosphorylcholine (AGEPC). 1987 Arch. Biochem. Biophys. pmid:3813566
Martins MA et al. Interactions between local inflammatory and systemic haematological effects of PAF-acether in the rat. 1987 Eur. J. Pharmacol. pmid:3609124
Mangold HK et al. Biologically active lipids. Semi-synthesis of 3H-labeled ether glycerophospholipids and ether glyceroglycolipids from ratfish liver oil. 1987 FEBS Lett. pmid:3609315
Caffrey E et al. Aggregation responses to platelet-activating factor in normal subjects. 1987 Haemostasis pmid:3609916
Baer PG and Cagen LM Platelet activating factor vasoconstriction of dog kidney. Inhibition by alprazolam. 1987 Hypertension pmid:3818022
Casals-Stenzel J Effects of WEB 2086, a novel antagonist of platelet activating factor, in active and passive anaphylaxis. 1987 Immunopharmacology pmid:3597059
Handley DA et al. Biological properties of the antagonist SRI 63-441 in the PAF and endotoxin models of hypotension in the rat and dog. 1987 Immunopharmacology pmid:3597060
Casals-Stenzel J et al. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. 1987 J. Pharmacol. Exp. Ther. pmid:3598913
Tokumura A et al. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. 1987 Thromb. Res. pmid:3647677
Dewald B and Baggiolini M Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay. 1987 Biochem. Pharmacol. pmid:3649232
Adler KB et al. Platelet activating factor stimulates secretion of mucin by explants of rodent airways in organ culture. 1987 Exp. Lung Res. pmid:3653044
Nakayama R et al. Existence of endogenous inhibitors of platelet-activating factor (PAF) with PAF in rat uterus. 1987 J. Biol. Chem. pmid:3654606
Shimazaki N et al. Diketopiperazines as a new class of platelet-activating factor inhibitors. 1987 J. Med. Chem. pmid:3656347
Ruan CG et al. Studies on monoclonal antibodies against human platelets--a monoclonal antibody to human platelet glycoprotein I--SZ-2. 1987 Sci. Sin., Ser. B, Chem. Biol. Agric. Med. Earth Sci. pmid:3659897
Kudo I et al. Antitumor activity of synthetic alkylphospholipids with or without PAF activity. 1987 Lipids pmid:3444379
Söling U et al. Effect of synthetic phospholipids on platelet aggregation and serotonin release. 1987 Lipids pmid:3444380
Schick HD et al. Cytotoxic effects of ether lipids and derivatives in human nonneoplastic bone marrow cells and leukemic cells in vitro. 1987 Lipids pmid:3444383
Danhauser S et al. Structure-cytotoxicity studies on alkyl lysophospholipids and some analogs in leukemic blasts of human origin in vitro. 1987 Lipids pmid:3444384
Oon SH and Williams N Immature megakaryocytes in the mouse: synergistic response to megakaryocyte potentiator, thrombopoietic stimulatory factor with interleukin 3. 1987 Leukemia pmid:3500375
Neuwirth R et al. Effect of platelet activating factor antagonists on cultured rat mesangial cells. 1987 J. Pharmacol. Exp. Ther. pmid:3119816
Fennessy MR et al. Lipid mediators of anaphylaxis and increased airways reactivity. 1987 Clin. Exp. Pharmacol. Physiol. pmid:2824102
Braquet P and Bourgain RH Anti-anaphylactic properties of BN 52021: a potent platelet activating factor antagonist. 1987 Adv. Exp. Med. Biol. pmid:3314403
Barnes PJ New concepts in the pathogenesis of bronchial hyperresponsiveness. 1987 Agents Actions Suppl. pmid:3314413
Mustard JF et al. Platelet activation--an overview. 1987 Agents Actions Suppl. pmid:3314414
Patrignani P et al. Platelet-activating factor (PAF) receptor antagonists inhibit mitogen-induced human peripheral blood T-cell proliferation. 1987 Biochem. Biophys. Res. Commun. pmid:2825672
Page CP and Robertson DN Properties of PAF relevant to asthma. 1987 Agents Actions Suppl. pmid:3314416
Földes-Filep E et al. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes. 1987 Biochem. Biophys. Res. Commun. pmid:2825685
Morley J PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. 1987 Agents Actions Suppl. pmid:3314417
Kimura Y et al. Effects of baicalein on leukotriene biosynthesis and degranulation in human polymorphonuclear leukocytes. 1987 Biochim. Biophys. Acta pmid:2825795
Braquet P et al. The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. 1987 Agents Actions Suppl. pmid:3314418
Rubin AH et al. The bronchoconstrictor properties of platelet-activating factor in humans. 1987 Am. Rev. Respir. Dis. pmid:3314611
Mathur RS et al. Current concepts in asthma. 1987 J Assoc Physicians India pmid:3320019
Chabot MC et al. Reacylation of platelet activating factor with eicosapentaenoic acid in fish-oil-enriched monkey neutrophils. 1987 Biochim. Biophys. Acta pmid:2823907
HÃ¥kansson L et al. New method for the measurement of eosinophil migration. 1987 J. Leukoc. Biol. pmid:2445885
Sciberras DG et al. Inflammatory responses to intradermal injection of platelet activating factor, histamine and prostaglandin E2 in healthy volunteers: a double blind investigation. 1987 Br J Clin Pharmacol pmid:2449904
Lecrubier C et al. [Platelet aggregation tests in 26 cases of heparin-induced thrombopenia. Methodological, diagnostic problems and therapeutic aspects]. 1987 J Mal Vasc pmid:2834484
Caramelo C et al. Increased levels of platelet-activating factor in blood from patients with cirrhosis of the liver. 1987 Eur. J. Clin. Invest. pmid:3106053
Steiger J et al. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. 1987 Eur. J. Pharmacol. pmid:3428351
Karasawa K et al. Antibody to platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine; PAF). 1987 J. Biochem. pmid:3429442
Stahl GL et al. PAF-acether induced cardiac dysfunction in the isolated perfused guinea pig heart. 1987 Naunyn Schmiedebergs Arch. Pharmacol. pmid:3431598
Spinnewyn B et al. Involvement of platelet-activating factor (PAF) in cerebral post-ischemic phase in Mongolian gerbils. 1987 Prostaglandins pmid:3432553
Guinot P et al. Effect of BN 52063, a specific PAF-acether antagonist, on bronchial provocation test to allergens in asthmatic patients. A preliminary study. 1987 Prostaglandins pmid:3432562
Touvay C et al. Gossypol: a potent inhibitor of PAF-acether- and leukotriene-induced contractions of guinea-pig lung parenchyma strips. 1987 J. Pharm. Pharmacol. pmid:2886603
Ho YS et al. Chemoattractant-induced activation of c-fos gene expression in human monocytes. 1987 J. Exp. Med. pmid:3108444
Hayashi M et al. Detection of platelet-activating factor in exudates of rats with phorbol myristate acetate-induced pleurisy. 1987 Thromb. Res. pmid:3433255
Sudan BJ Ketoconazole, leukotrienes, Paf-acether and nicotine as a hapten: the possible aetiology of seborrhoeic dermatitis. 1987 Med. Hypotheses pmid:2886895
Kurachi M et al. Suppression of bronchial response to platelet activating factor following taurine administration. 1987 Adv. Exp. Med. Biol. pmid:3434419
Matsuno K et al. [Cytoplasm free calcium ions as a second messenger]. 1987 Rinsho Byori pmid:3437533
Ostermann G et al. Modification of the polar head group of platelet-activating factor: influence on the biological activity. 1987 Chem. Phys. Lipids pmid:3607969
Maudsley DJ and Morris AG Rapid intracellular calcium changes in U937 monocyte cell line: transient increases in response to platelet-activating factor and chemotactic peptide but not interferon-gamma or lipopolysaccharide. 1987 Immunology pmid:3110054
Sugatani J et al. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. 1987 J. Biol. Chem. pmid:2824509
McIntyre TM et al. Protein kinase C activity appears to be required for the synthesis of platelet-activating factor and leukotriene B4 by human neutrophils. 1987 J. Biol. Chem. pmid:2824456
Hartiala KT et al. Lack of correlation between calcium mobilization and respiratory burst activation induced by chemotactic factors in rabbit polymorphonuclear leukocytes. 1987 Biochem. Biophys. Res. Commun. pmid:3034265
Sperling RI et al. The effects of N-3 polyunsaturated fatty acids on the generation of platelet-activating factor-acether by human monocytes. 1987 J. Immunol. pmid:2826583
Musch MW et al. Antigen-and ionophore-stimulated synthesis of platelet-activating factor by the cloned mast cell line, MC9. 1987 Biochem. Biophys. Res. Commun. pmid:3107564
Sisson JH et al. Production of platelet-activating factor by stimulated human polymorphonuclear leukocytes. Correlation of synthesis with release, functional events, and leukotriene B4 metabolism. 1987 J. Immunol. pmid:3035016
Michel L et al. Biologic properties of LTB4 and paf-acether in vivo in human skin. 1987 J. Invest. Dermatol. pmid:3035030
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. 1987 Agents Actions Suppl. pmid:3478993
Farr RS et al. Platelet abnormalities in asthma--do they exist in humans? 1987 Agents Actions Suppl. pmid:3478994
Menz G et al. Lack of PAF release in extrinsic asthma. 1987 Agents Actions Suppl. pmid:3478995
Szczeklik A et al. Bleeding time and PAF-acether-induced platelet aggregation in atopy. 1987 Agents Actions Suppl. pmid:3478996
Schmitz-Schumann M et al. Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. 1987 Agents Actions Suppl. pmid:3478999
Guinot P et al. Effects of BN 52063 on PAF-acether induced weal and flare in man. 1987 Agents Actions Suppl. pmid:3479000
Lang M et al. Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. 1987 Agents Actions Suppl. pmid:3479001
Codde JP et al. Effects of altered prostanoid and lyso-PAF synthesis by marine oil diets on blood pressure of salt loaded spontaneously hypertensive rats. 1987 Agents Actions Suppl. pmid:3481207
Sweatt JD et al. Evidence for a role for Na+-H+ exchange in activation of human platelets by PAF. 1987 Circ. Res. pmid:2822286
Kurgan J [Blood platelets and asthma and other lung diseases]. 1987 Pol Tyg Lek pmid:3684765
Ezra D et al. Cardiac and coronary consequences of intracoronary platelet activating factor infusion in the domestic pig. 1987 Prostaglandins pmid:3685397
Benhamou M and Mencia-Huerta JM Effect of glucocorticosteroids on the expression of Fc epsilon R1 and on mediator release from mast cells. 1986 Sep-Oct Ann. Inst. Pasteur Immunol. pmid:2948525
Morley J Theophylline in asthma. 1986 Sep-Oct Bull Eur Physiopathol Respir pmid:3801711
von Tscharner V et al. Ion channels in human neutrophils activated by a rise in free cytosolic calcium concentration. 1986 Nov 27-Dec 3 Nature pmid:2431318
Kako KJ Membrane phospholipids and plasmalogens in the ischemic myocardium. 1986 May-Jun Can J Cardiol pmid:2424580
Rosam AC et al. Potent ulcerogenic actions of platelet-activating factor on the stomach. 1986 Jan 2-8 Nature pmid:3510396
Nishihira J and Ishibashi T A phospholipase C with a high specificity for platelet-activating factor in rabbit liver light mitochondria. 1986 Lipids pmid:3821393
Schlondorff D et al. Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells. 1986 Biochem. Biophys. Res. Commun. pmid:3099783